Diabetes Risk
Calculator India

A diabetes risk calculator screens for a higher chance of having undiagnosed Type 2 diabetes (T2DM) or developing it later, using published clinical scoring tools. This calculator runs two engines simultaneously: a DietXP South Asian-Adapted FINDRISC (based on the Finnish Diabetes Risk Score, modified for Indian adults) and IDRS (Indian Diabetes Risk Score, Mohan et al. 2005). Both tools assign weighted clinical points to risk factors including age, BMI, waist circumference, physical activity, diet, blood pressure medication, blood glucose history, and family history. The two scores are then displayed independently and mapped to one DietXP screening interpretation using a pre-specified two-score follow-up rule, so neither engine alone can produce an extreme classification. This rule is DietXP's own screening-interpretation approach; it has not been separately validated as a combined diagnostic or prediction model.

Indians and South Asians develop Type 2 diabetes at lower body weight and waist circumference than European populations, a phenomenon called the 'Asian Indian phenotype.' Standard FINDRISC was validated on Finnish cohorts with European BMI and waist norms that miss many at-risk Indians. This calculator uses Asian public-health BMI action points (≥23 kg/m² overweight, ≥27.5 kg/m² obese) and IDRS waist-scoring bands aligned with South Asian central-obesity thresholds (Men ≥90 cm, Women ≥80 cm). It also pairs FINDRISC with the IDRS, which was specifically validated on large Indian urban cohorts, so this tool presents both scores together for a more complete picture than FINDRISC alone. The combined interpretation rule itself has not been separately validated.

FINDRISC (Finnish Diabetes Risk Score) is a 7-item validated questionnaire developed by Lindström and Tuomilehto (Diabetes Care, 2003). It scores age, BMI, waist circumference, physical activity, vegetable/fruit intake, blood pressure medication, and blood glucose history on a scale of 0–26. In the original Finnish validation, FINDRISC scores of <7 were associated with low risk (~1% 10-year T2DM) up to >20 very high (~50%); those percentages describe the original, unmodified instrument in a Finnish cohort. This calculator uses a DietXP South Asian-Adapted FINDRISC with different BMI and waist action points for Indian adults, and flags a 'Gray Zone' when your score falls between two internal thresholds (11 and 14). Because this adapted version has not been separately validated, this tool does not attach a sensitivity or specificity figure to that Gray Zone threshold, and the original Finnish-cohort percentages above are not recalculated or shown for your result.

The Indian Diabetes Risk Score was developed by Dr. V. Mohan and colleagues at the Madras Diabetes Research Foundation (JAPI, 2005) using data from the CURES Chennai cohort. It uses 4 parameters (age, waist circumference, physical activity, and family history) scored out of 100. In the original IDRS derivation/internal-validation study, a score of ≥60 indicated High Risk for previously undiagnosed diabetes (by the study's glucose criterion) with AUC 0.698, sensitivity 72.5%, specificity 60.1%, PPV 17.0%, and NPV 95.1%. Those are the original study's figures, not a current nationwide India-wide performance value. Its scoring weights were derived entirely from Indian population data.

Your DietXP screening interpretation is calculated from both FINDRISC and IDRS together using a pre-specified two-score follow-up rule, not a separately validated combined model. The ordered decision tree is: Prompt Clinician Review Recommended when FINDRISC >14 and IDRS ≥60; Screening Strongly Recommended when FINDRISC 11-14 and IDRS ≥60; Screening Follow-Up Recommended when FINDRISC ≥11 or IDRS ≥30; Slightly Elevated when FINDRISC ≥7 or IDRS ≥20; otherwise Low. A single engine scoring high alone lands in Screening Follow-Up Recommended with a suggestion to discuss blood-glucose testing, rather than an overstated higher result. This rule has not been separately validated to produce a personalised 10-year percentage, so the tool reports an interpretation band and a recommended next step rather than a probability.

Low: Maintain healthy habits. Ask your clinician how often to repeat FPG + HbA1c screening if you are aged 35+.
Slightly Elevated: A clinician or dietitian can help set an achievable weight-management goal and an activity routine. In the Diabetes Prevention Program RCT (NEJM, 2002), structured lifestyle support reduced T2DM incidence by 58% over an average 2.8 years in that trial's high-risk study population, not a guaranteed individual result.
Screening Follow-Up Recommended (Gray Zone or discordant scores): Discuss whether FPG and HbA1c testing are appropriate with a physician or clinical dietitian.
Screening Strongly Recommended / Prompt Clinician Review Recommended: Physician follow-up for diagnostic testing is recommended, with how soon depending on your individual profile. Diabetes is diagnosed only through appropriate laboratory testing, which may include HbA1c, fasting plasma glucose, a 2-hour oral glucose tolerance test, or random plasma glucose with classic symptoms, per ADA Standards of Care in Diabetes 2026 and WHO Classification of diabetes mellitus (2019). Consider booking a dietitian consultation below to build a personalised prevention plan.

No. This is a screening tool only; it estimates risk, not diagnosis. Diabetes can be diagnosed only through appropriate laboratory testing. Depending on the clinical situation, this may include HbA1c, fasting plasma glucose, a 2-hour oral glucose tolerance test, or random plasma glucose with classic symptoms, per ADA Standards of Care in Diabetes 2026 and WHO Classification of diabetes mellitus (2019). In the absence of unequivocal hyperglycaemia, confirmatory abnormal results on two occasions are required. Prediabetes is defined as FPG 100–125 mg/dL or HbA1c 5.7–6.4%. If your result shows Screening Strongly Recommended or Prompt Clinician Review Recommended, please consult a qualified physician or endocrinologist for formal diagnostic testing.

This calculator uses IDRS waist-scoring bands, aligned with the IDF South Asian central-obesity threshold: Men: less than 90 cm (lower band), 90–99 cm (intermediate band), ≥100 cm (higher band); Women: less than 80 cm (lower band), 80–89 cm (intermediate band), ≥90 cm (higher band). IDF's own published threshold is a single cutoff (men 90 cm, women 80 cm); the intermediate/higher split above is the IDRS scoring structure's own banding, not a separate IDF three-tier classification. These thresholds are substantially lower than European WHO cutoffs (Men >102 cm, Women >88 cm) because South Asians accumulate more visceral fat at lower overall body weight, which is a stronger driver of insulin resistance than subcutaneous fat. Using European cutoffs misses a large number of Indian adults who are metabolically at-risk despite appearing 'normal' on a standard chart.